P-282 Can additional RF delivery after successful pulmonary vein isolation reduce recurrence of atrial fibrillation? [PDF]
Takumi Yamada+6 more
openalex +3 more sources
Chinese Expert Consensus on Critical Care Ultrasound Applications at COVID-19 Pandemic [PDF]
The spread of new coronavirus (SARS-Cov-2) follows a different pattern than previous respiratory viruses, posing a serious public health risk worldwide. World Health Organization (WHO) named the disease as COVID-19 and declared it a pandemic. COVID-19 is
Cui, MD, Ligang+19 more
core +1 more source
Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail+5 more
wiley +1 more source
ЭФФЕКТИВНОСТЬ ПРИМЕНЕНИЯ КОЛХИЦИНА ДЛЯ ПРОФИЛАКТИКИ РЕЦИДИВА ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ ПОСЛЕ ИЗОЛЯЦИИ ЛЕГОЧНЫХ ВЕН: РЕЗУЛЬТАТЫ ДВОЙНОГО СЛЕПОГО ПЛАЦЕБО-КОНТРОЛИРУЕМОГО ИССЛЕДОВАНИЯ [PDF]
Deftereos S., Giannopoulos G., Efremidis M., et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life // heart Rhythm. – 2014. Feb 4. [Epub ahead of print]Источник:
, статья Редакционная
core +1 more source
Durability of Pulmonary Vein Isolation Using Pulsed-Field Ablation:Results From the Multicenter EU-PORIA Registry [PDF]
BACKGROUND: Pulsed-field ablation (PFA) is a novel nonthermal ablation technology with high procedural safety and efficiency for pulmonary vein isolation (PVI). Premarket data showed high PVI durability during mandatory remapping studies.
Adelino, Raquel+19 more
core +1 more source
A self‐assembling, aggregation‐enhanced tetrahedral DNA nanostructure (tFNA), termed TACs, enables localized accumulation and sustained release of ceftriaxone while co‐delivering antisense oligonucleotides that silence mecA, reduce PBP2a expression, and restore β‐lactam susceptibility in MRSA.
Yicheng Zhao+10 more
wiley +1 more source
A08-5 Feasibility and safety of pulmonary vein isolation using a new mapping and ablation system in patients with refractory atrial fibrillation [PDF]
Thomas Arentz+6 more
openalex +3 more sources
A08-2 Significance of atrial capture during distal pulmonary vein pacing after ostial isolation of the pulmonary veins [PDF]
Massimo Tritto+8 more
openalex +3 more sources
A25-6 Structural heart disease does not affect outcomes of pulmonary vein isolation for treatment of atrial fibrillation [PDF]
Yaariv Khaykin+14 more
openalex +3 more sources
Pulmonary Vein Isolation for Chronic Atrial Fibrillation Associated with Mitral Valve Disease.
Hiroyuki Tanaka+4 more
openalex +2 more sources